Specific Biologics grabs first-time VC led by Lumira, adMare

Toronto-based Specific Biologics, a biotechnology company focused on developing technologies to treat diseases through precision gene editing, has raised a first-time financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this